Literature DB >> 3107689

Treating Paget's disease.

D A Heath.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3107689      PMCID： PMC1246216          DOI： 10.1136/bmj.294.6579.1048

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  19 in total

1.  Treatment of Paget's disease of bone with synthetic human calcitonin: biochemical and roentgenologic changes.

Authors:  P B Greenberg; F H Doyle; M T Fisher; C J Hillyard; G F Joplin; J Pennock; I MacIntyre
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

2.  Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment.

Authors:  J DeRose; F R Singer; A Avramides; A Flores; R Dziadiw; R K Baker; S Wallach
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

Review 3.  Paget's disease: improvement of spinal cord dysfunction with diphosphonates and calcitonin.

Authors:  D L Douglas; J A Kanis; T Duckworth; D J Beard; A D Paterson; R G Russell
Journal:  Metab Bone Dis Relat Res       Date:  1981

4.  Histologic changes in Paget's disease treated with calcitonin.

Authors:  V L Fornasier; K Stapleton; C C Williams
Journal:  Hum Pathol       Date:  1978-07       Impact factor: 3.466

5.  Paget's bone disease treated with diphosphonate and calcitonin.

Authors:  D J Hosking; O L Bijvoet; J van Aken; E J Will
Journal:  Lancet       Date:  1976-03-20       Impact factor: 79.321

6.  Pathologic fracture due to severe osteomalacia following low-dose diphosphonate treatment of Paget's disease of bone.

Authors:  R A Evans; C R Dunstan; E Hills; S Y Wong
Journal:  Aust N Z J Med       Date:  1983-06

7.  Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.

Authors:  M C Chapuy; S A Charhon; P J Meunier
Journal:  Metab Bone Dis Relat Res       Date:  1983

8.  Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results.

Authors:  M R Khairi; R D Altman; G P DeRosa; J Zimmermann; R K Schenk; C C Johnston
Journal:  Ann Intern Med       Date:  1977-12       Impact factor: 25.391

9.  Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day).

Authors:  C M Alexandre; M C Chapuy; E Vignon; C Edouard; C C Johnston; P J Meunier
Journal:  Clin Orthop Relat Res       Date:  1983-04       Impact factor: 4.176

10.  Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).

Authors:  C C Johnston; R D Altman; R E Canfield; G A Finerman; J D Taulbee; M L Ebert
Journal:  Clin Orthop Relat Res       Date:  1983 Jan-Feb       Impact factor: 4.176
View more
  1 in total

1.  Clinical experience with pamidronate in the treatment of Paget's disease of bone.

Authors:  S J Gallacher; B F Boyce; U Patel; A Jenkins; S H Ralston; I T Boyle
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.